Co-administration of GnRH-agonist and hCG for final oocyte maturation, 40 and 34 hours prior to OPU, respectively (double trigger), is suggested as a valuable new tool in the armamentarium for treating patients with low/poor oocytes yield despite an apparently normal follicular development and E2 levels and in the presence of optimal hCG levels on the day of OPU.
No takes yet. Share an insight, caveat, or question.
Haas et al. (2014) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: